NCT00903253
A Double-Blind, Placebo Controlled, Single, Escalating Dose Study to Evaluate the Preliminary Pharmacokinetics, Safety and Tolerability of LNK-754 in Healthy Elderly Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: May 31, 2009
Completion: Sep 30, 2009